Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,442
Award facts
- Contract value 100% obligated
- $24,442.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $24,442.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and carries no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This single-award IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. The contract demonstrates Cencora and AmerisourceBergen's established capability to efficiently fulfill government requirements for essential pharmaceutical materials required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FJH5J?
SPE2DR26FJH5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FJH5J worth?
The government has obligated $24,442 on SPE2DR26FJH5J.
Is contract SPE2DR26FJH5J an order under another contract?
Yes. SPE2DR26FJH5J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH5J competed?
The extent of competition for SPE2DR26FJH5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award